Lung Cancer Risk Test (LCRT-AGX) 14 Gene Test

Clinical Utility: To identify patients at highest risk for developing lung cancer so they can be closely monitored to detect lung cancer in its early stages when its most treatable

Intended For: Patients at highest risk for developing lung cancer

Prescribed By: Pulmonologists

Performed In: Multiple CLIA laboratories

Current status: recruiting patients for clinical trial.

Lung cancer remains the most common cause of cancer death in the United States (160,000 deaths each year). A recent NIH sponsored study determined that yearly chest CT scan reduces mortality from lung cancer by more than 20%. However, the cost of annually screening all 7 million individuals at risk for lung cancer due to age and smoking history would be more than $5 billion/year. The Lung Cancer Risk Test promises to identify the individuals genetically pre-disposed to lung cancer so that they can be prioritized for screening. This will markedly reduced cost of CT screening.

 

return to main diagnostics page

jordan 11 legend blue jordan 11 legend blue black infrared 6s legend blue 11s Lebron 11 jordan 11 legend blue black infrared 6s jordan 11 legend blue louis vuitton outlet barons 13s jordan 6 black infrared jordan 11 legend blue jordan 6 black infrared jordan 6 black infrared legend blue 11s jordan retro 6 Legend Blue 11s lebron 12 lebron 12 jordan retro 11 jordan retro 11 jordan 11 legend blue beats by dre cheap legend blue 11s michael kors outlet louis vuitton outlet sac louis vuitton legend blue 11s louis vuitton outlet legend blue 11s beats by dre black friday uggs black friday louis vuitton outlet lebron 12 jordan 6 black infrared louis vuitton outlet legend blue 11s jordan 6 black infrared legend blue 11s michael kors outlet